Sven De Vos - Department of Hematology and Oncology, University of California, Los Angeles

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 225 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7)

Simone Filosto,Saran Vardhanabhuti, Miguel A. Canales,Xavier Poire,Lazaros J. Lekakis,Sven de Vos,Craig A. Portell,Zixing Wang,Christina To,Marco Schupp,Soumya Poddar,Tan Trinh, Carmen M. Warren, Ethan G. Aguilar,Justin Budka,Paul Cheng,Justin Chou,Adrian Bot,Rhine R. Shen,Jason R. Westin

BLOOD CANCER DISCOVERYno. 1 (2024): 21-33

Cited0Views0WOSBibtex

Zilovertamab Vedotin (MK‐2140) in Relapsed or Refractory (R/R) Non‐hodgkin Lymphoma (NHL): 14‐month Follow‐up of the Phase 1 Waveline‐001 Study

M. L. Wang,Matthew Mei,Paul M. Barr,Jacqueline C. Barrientos,Sven de Vos,Richard R. Furman,Krish Patel,William G. Wierda, Moon Young Choi,Avyakta Kallam, S. Wang,Uzor C. Ogbu,Patricia Marinello,Stephen E. Spurgeon

Hematological oncologyno. S2 (2023): 571-572

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn